Development and preliminary assessment of a CRISPR–Cas12a-based multiplex detection of Mycobacterium tuberculosis complex

Since the onset of the COVID-19 pandemic in 2020, global efforts towards tuberculosis (TB) control have encountered unprecedented challenges. There is an urgent demand for efficient and cost-effective diagnostic technologies for TB. Recent advancements in CRISPR–Cas technologies have improved our ca...

Полное описание

Библиографические подробности

Главные авторы:	Jing Xiao, Jieqiong Li, Shuting Quan, Yacui Wang, Guanglu Jiang, Yi Wang, Hairong Huang, Weiwei Jiao, Adong Shen
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2023-08-01
Серии:	Frontiers in Bioengineering and Biotechnology
Предметы:	Mycobacterium tuberculosis complex CRISPR-Cas12a multiplex detection fluorescent biosensor lateral flow biosensor point-of-care testing
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fbioe.2023.1233353/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!